查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
不孕診斷與治療市場報告：2030 年趨勢、預測與競爭分析
市場調查報告書
商品編碼
1356790

不孕診斷與治療市場報告：2030 年趨勢、預測與競爭分析

Infertility Diagnosis and Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

不孕診斷和治療的趨勢和預測

至2030年，全球不孕診斷和治療市場預計將達到29億美元，2024年至2030年年複合成長率為7.9%。市場的主要促進因素是出生率下降、各種不孕治療方案的可用性增加以及世界各地不孕治療中心數量的增加。不孕不孕診斷和治療市場前景廣闊，男性和女性不孕治療市場蘊藏商機。

不孕診斷與治療市場洞察

  • Lucintel 預測，女性不孕診斷在預測期內將出現高速成長。
  • 女性不孕治療仍是最大的部分。
  • 由於生活方式的改變和老年人口的增加，北美在預測期內將繼續成為最大的市場。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球不孕診斷與治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球不孕診斷和治療市場趨勢（2018-2023）和預測（2024-2030）
  • 全球不孕診斷和治療市場（按診斷）
    • 男性不孕的診斷
    • 女性不孕的診斷
  • 按治療分類的全球不孕診斷與治療市場
    • 男性不孕治療
    • 女性不孕治療
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球不孕診斷與治療市場（按地區）
  • 北美不孕診斷與治療市場
  • 歐洲不孕診斷與治療市場
  • 亞太不孕診斷與治療市場
  • 其他區域不孕診斷與治療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球不孕診斷與治療市場診斷成長機會
    • 全球不孕診斷和治療市場成長機會（按治療）
    • 全球不孕診斷和治療市場按地區成長機會
  • 全球不孕診斷和治療市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球不孕診斷和治療市場的能力
    • 全球不孕診斷和治療市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Bayer AG
  • Bristol-Myers Squibb
  • Church & Dwight
  • Cook Medical
  • Coopersurgical
  • Eli Lilly
  • EMD Serono
  • Endo Pharmaceuticals
  • Ferring Pharmaceuticals
  • Genea
簡介目錄

Infertility Diagnosis and Treatment Trends and Forecast

The future of the global infertility diagnosis and treatment market looks promising with opportunities in the male infertility treatment and female infertility treatment markets. The global infertility diagnosis and treatment market is expected to reach an estimated $2.9 billion by 2030 with a CAGR of 7.9% from 2024 to 2030. The major drivers for this market are declining fertility rate, increasing availability of various fertility treatment options, and rising number of fertility centers across the globe.

A more than 150-page report is developed to help in your business decisions.

Infertility Diagnosis and Treatment by Segment

The study includes a forecast for the global infertility diagnosis and treatment by diagnosis, treatment, and region.

Infertility Diagnosis and Treatment Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Male Infertility Diagnosis
  • Female Infertility Diagnosis

Infertility Diagnosis and Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Male Infertility Treatment
  • Female Infertility Treatment
  • Others

Infertility Diagnosis and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Infertility Diagnosis and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infertility diagnosis and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infertility diagnosis and treatment companies profiled in this report include-

  • Bayer AG
  • Bristol-Myers Squibb
  • Church & Dwight
  • Cook Medical
  • Coopersurgical
  • Eli Lilly
  • EMD Serono
  • Endo Pharmaceuticals
  • Ferring Pharmaceuticals
  • Genea

Infertility Diagnosis and Treatment Market Insights

  • Lucintel forecasts that female infertility diagnosis is expected to witness higher growth over the forecast period.
  • Female infertility treatment will remain the largest segment.
  • North America will remain the largest segment over the forecast period due to the changing lifestyle and growing geriatric population.

Features of the Global Infertility Diagnosis and Treatment Market

  • Market Size Estimates: Infertility diagnosis and treatment market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Infertility diagnosis and treatment market size by diagnosis, treatment, and region. in terms of value ($B).
  • Regional Analysis: Infertility diagnosis and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatments, and region.s for the infertility diagnosis and treatment market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infertility diagnosis and treatment market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the infertility diagnosis and treatment market size?

Answer: The global infertility diagnosis and treatment market is expected to reach an estimated $2.9 billion by 2030.

Q.2. What is the growth forecast for infertility diagnosis and treatment market?

Answer: The global infertility diagnosis and treatment market is expected to grow with a CAGR of 7.9% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the infertility diagnosis and treatment market?

Answer: The major drivers for this market are declining fertility rate, increasing availability of various fertility treatment options, and rising number of fertility centers across the globe.

Q.4. What are the major segments for infertility diagnosis and treatment market?

Answer: The future of the global infertility diagnosis and treatment market looks promising with opportunities in the male infertility treatment and female infertility treatment markets.

Q.5. Who are the key infertility diagnosis and treatment market companies?

Answer: Some of the key infertility diagnosis and treatment companies are as follows:

  • Bayer AG
  • Bristol-Myers Squibb
  • Church & Dwight
  • Cook Medical
  • Coopersurgical
  • Eli Lilly
  • EMD Serono
  • Endo Pharmaceuticals
  • Ferring Pharmaceuticals
  • Genea

Q.6. Which infertility diagnosis and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that female infertility diagnosis is expected to witness higher growth over the forecast period.

Q.7. In infertility diagnosis and treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to the changing lifestyle and growing geriatric population.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the infertility diagnosis and treatment market by diagnosis (male infertility diagnosis and female infertility diagnosis), treatment (male infertility treatment, female infertility treatment, and Others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Infertility Diagnosis and Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Infertility Diagnosis and Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Infertility Diagnosis and Treatment Market by Diagnosis
    • 3.3.1: Male Infertility Diagnosis
    • 3.3.2: Female Infertility Diagnosis
  • 3.4: Global Infertility Diagnosis and Treatment Market by Treatment
    • 3.4.1: Male Infertility Treatment
    • 3.4.2: Female Infertility Treatment
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Infertility Diagnosis and Treatment Market by Region
  • 4.2: North American Infertility Diagnosis and Treatment Market
    • 4.2.2: North American Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others
  • 4.3: European Infertility Diagnosis and Treatment Market
    • 4.3.1: European Infertility Diagnosis and Treatment Market by Diagnosis: Male Infertility Diagnosis and Female Infertility Diagnosis
    • 4.3.2: European Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others
  • 4.4: APAC Infertility Diagnosis and Treatment Market
    • 4.4.1: APAC Infertility Diagnosis and Treatment Market by Diagnosis: Male Infertility Diagnosis and Female Infertility Diagnosis
    • 4.4.2: APAC Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others
  • 4.5: ROW Infertility Diagnosis and Treatment Market
    • 4.5.1: ROW Infertility Diagnosis and Treatment Market by Diagnosis: Male Infertility Diagnosis and Female Infertility Diagnosis
    • 4.5.2: ROW Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Infertility Diagnosis and Treatment Market by Diagnosis
    • 6.1.2: Growth Opportunities for the Global Infertility Diagnosis and Treatment Market by Treatment
    • 6.1.3: Growth Opportunities for the Global Infertility Diagnosis and Treatment Market by Region
  • 6.2: Emerging Trends in the Global Infertility Diagnosis and Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Infertility Diagnosis and Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Infertility Diagnosis and Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bayer AG
  • 7.2: Bristol-Myers Squibb
  • 7.3: Church & Dwight
  • 7.4: Cook Medical
  • 7.5: Coopersurgical
  • 7.6: Eli Lilly
  • 7.7: EMD Serono
  • 7.8: Endo Pharmaceuticals
  • 7.9: Ferring Pharmaceuticals
  • 7.10: Genea